Literature DB >> 22249348

Posaconazole serum level on day 2 predicts steady state posaconazole serum level.

Myke R Green, Joseph E Woolery.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22249348     DOI: 10.1097/FTD.0b013e31823cef77

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


× No keyword cloud information.
  4 in total

1.  Posaconazole Plasma Concentrations on Days Three to Five Predict Steady-State Levels.

Authors:  Jürgen Prattes; Wiebke Duettmann; Martin Hoenigl
Journal:  Antimicrob Agents Chemother       Date:  2016-08-22       Impact factor: 5.191

2.  The Genetic Polymorphism UGT1A4*3 Is Associated with Low Posaconazole Plasma Concentrations in Hematological Malignancy Patients Receiving the Oral Suspension.

Authors:  Hyeon Jeong Suh; Seo Hyun Yoon; Kyung-Sang Yu; Joo-Youn Cho; Sang-In Park; Eunyoung Lee; Jeong-Ok Lee; Youngil Koh; Kyoung-Ho Song; Pyoeng Gyun Choe; Eu Suk Kim; Soo-Mee Bang; Hong Bin Kim; Inho Kim; Nam Joong Kim; Sang Hoon Song; Wan Beom Park; Myoung-Don Oh
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

Review 3.  Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology.

Authors:  H Ruth Ashbee; Rosemary A Barnes; Elizabeth M Johnson; Malcolm D Richardson; Rebecca Gorton; William W Hope
Journal:  J Antimicrob Chemother       Date:  2013-12-29       Impact factor: 5.790

Review 4.  Therapeutic Drug Monitoring of Posaconazole: an Update.

Authors:  Bart G J Dekkers; Martijn Bakker; Kim C M van der Elst; Marieke G G Sturkenboom; Anette Veringa; Lambert F R Span; Jan-Willem C Alffenaar
Journal:  Curr Fungal Infect Rep       Date:  2016-05-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.